The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective-retrospective HeCOG phase III trial validation of Polaris TME for the prediction of TILs from whole-slide images in high-risk early breast cancer.
 
Elena Fountzilas
Stock and Other Ownership Interests - Deciphera; Genprex
Honoraria - Amgen; AstraZeneca; AstraZeneca (I); Pfizer; Roche; Roche/Genentech
Consulting or Advisory Role - Amgen; Pfizer (I); Roche (I); Sanofi (I)
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharmaceuticals; Pfizer
 
Marta Ligero
Employment - StratifAI GmbH
Consulting or Advisory Role - StratifAI GmbH
 
Eleni (Helen) Kourea
No Relationships to Disclose
 
Anna Goussia
No Relationships to Disclose
 
Olympia Tzaida
No Relationships to Disclose
 
Triantafyllia Koletsa
No Relationships to Disclose
 
Mattheos Bobos
No Relationships to Disclose
 
Katerina Zarampouka
No Relationships to Disclose
 
Ioannis Binas
No Relationships to Disclose
 
Dimitrios Pectasides
Honoraria - Astellas Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; MSD; Roche
 
Maurits Engbersen
Employment - DeepHealth; Stratifai Gmbh
Stock and Other Ownership Interests - Cimcure BV (I); RadNet
Research Funding - Cimcure BV (I)
 
Athina Christopoulou
No Relationships to Disclose
 
Kyriaki Papadopoulou
No Relationships to Disclose
 
Helena Linardou
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Pfizer; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; MSD Oncology; Pfizer; Roche; Sandoz
Travel, Accommodations, Expenses - Merck; Pfizer Hellas; Vianex
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
 
Angelos Koutras
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Genesis Pharma; Gilead Sciences; MSD; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Gilead Sciences; Sandoz; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharma; Gilead Sciences; Ipsen; Lilly; Pfizer; Rafarm
 
Helen Gogas
Honoraria - Bristol-Myers Squibb; Genesis Pharmaceuticals; MSD Oncology; Pierre Fabre; Sanofi/Regeneron
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pierre Fabre; Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); MSD Oncology (Inst); Novartis (Inst); Replimune (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD; Pfizer; Sanofi
 
George Fountzilas
Stock and Other Ownership Interests - Deciphera (I); Genprex; Genprex (I)
Consulting or Advisory Role - Amgen (I); Daiichi (I)
Speakers' Bureau - AstraZeneca (I); Genesis Pharmaceuticals (I); GlaxoSmithKline (I); Lilly (I)
Travel, Accommodations, Expenses - AstraZeneca (I); Daiichi (I); Genesis Pharmaceuticals (I); K.A.M Oncology/Hematology (I); Pfizer (I)
 
Jakob Kather
Stock and Other Ownership Interests - Spira Labs; StratifAI; Synagen
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Fresenius; Janssen; Merck; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bioptimus
Research Funding - AstraZeneca; GlaxoSmithKline
 
Omar El Nahhas
Employment - StratifAI GmbH
Leadership - StratifAI GmbH
Stock and Other Ownership Interests - StratifAI GmbH